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In recent years, a significant increase in mortality of patients with fungal infections has been 
observed.  This is primarily due to a higher incidence of individuals who are 
immunocompromised including HIV-infected patients, patients undergoing cancer therapy, 
organ transplant recipients, and patients with advanced stages of diabetes. A complication in 
treating patients with fungal infections is the development of drug resistant fungi. With the 
limited number of effective antifungal drugs and the increase of drug resistance, fungal 
infections and pathogenesis is a major threat to human health.  The proposed studies help to 
solve this issue by identifying genes that alter antifungal drug sensitivity.  Our central hypothesis 
is that a subset of transcriptional regulators are needed for pathways critical for altering 
antifungal drug resistance.  This project used growth assays to determine the effects of the 
antifungal drugs, ketoconazole and amphotericin B, on yeast deletions strains.  Overall, the 
proposed work will have an impact on human health related to fungal pathogenesis and drug 
resistance.   
  
 
